A new study predicts that the global burden of Parkinson’s disease will more than double by 2050, reaching 25.2 million cases, driven by population growth and aging. The findings highlight the urgent need for new treatments and social support, particularly as lower- and middle-income countries will see the sharpest increases. Factors contributing to the rise include decreased physical activity and environmental pollutants. Experts emphasize the necessity for investments in healthcare and support services for those affected.